The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.
New diagnostic and therapeutic tools are in development to inform the management of advanced and metastatic disease.
Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.
A shift toward multidisciplinary care is inevitable for the treatment of locally advanced and metastatic RCC.
Regular exercise can help patients with cancer deal with issues related to weight gain during treatment.
A recent study is the first to demonstrate the cumulative effect of a large number of lifestyle behaviors.
Two cases raise the question of whether abnormal activation of the hedgehog signaling pathway can lead to a protective effect on melanomas.
As oncologists learn to target the immune response to "self and non-self," a delicate therapy balance will eventually be achieved with predictable outcomes, benefits, and toxicity in the fight against cancer.
Clinical trial data regarding deep molecular response outcomes suggest that dasatinib and nilotinib are superior to the first-generation TKI, imatinib.
Cancer Therapy Advisor interviewed Dr Li about her research into the relationship between periodontal disease and gastric cancer.
Hypofractionated radiotherapy's role in postoperative settings remains unclear and awaits outcomes from ongoing studies.
TLS considered an emergency, so it's crucial to initiate therapy as soon as possible.
Novel algorithms may be able to diagnose and plan cancer treatments more effectively than humans, but it's unclear if and when artificial intelligence will be integrated into clinical practice.
Studying how MGUS and myeloma clones change over time might yield new insights into myeloma's molecular heterogeneity.
Study findings suggest that some clinicians are using immunotherapies in the types of patients not included in clinical trials.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Hyperthermia Plus Chemotherapy Improves Survival in Soft Tissue Sarcoma
- Survey May Help To Identify Patients With Cancer at Risk of HBV Reactivation
- Fish Consumption and Cancer
- Socioeconomic Status May Preclude Elderly Patients From Receiving Pancreatic Cancer Treatment
- Receptor Agonists With Palonosetron May Reduce Needed Dexamethasone Duration